Search Results for: Medicine
(5 results)

Medicine: Deep dive – multiple myeloma

Multiple myeloma (MM) is a hematological malignancy characterised by the clonal proliferation of malignant plasma cells in the bone marrow.

PUBLISHED IN Deep Dive Articles: DECEMBER 2024

Medicine: MedTech – New more stringent European MDR regulations and changes in MedTech

The European Parliament’s Regulation (EU) 2017/745 on medical devices (MDR)[1] is a new set of regulations that governs the production and distribution of medical devices within the European Union (EU).

PUBLISHED IN News in Review: APRIL 2024

Medicine: Digital health (Ref: Global Digital Health Innovation 2023)

Clinical strength in digital health is gaining pace, which augurs well for adoption and complementing traditional clinical interventions and diagnostics.

PUBLISHED IN News in Review: APRIL 2024

Medicine: Weighing up the Ozempic hype – GLP-1 agonists and the obesity epidemic

Glucagon-like peptide-1 agonists (GLP-1 agonists) are a class of medications used to manage type 2 diabetes.

PUBLISHED IN Hot Topics: APRIL 2024

NeuroScience Psychology: Deep dive – understanding dementia

The Science of Understanding Dementia Dementia is a broad term for a collection of symptoms, characterised by a decline in memory and other cognitive abilities, which are caused by disorders affecting the brain. Dementia is therefore more of a syndrome rather than one specific disease.

PUBLISHED IN Deep Dive Articles: APRIL 2024

Life Sciences Researcher

Chris Kallos is a highly qualified life sciences professional with a wealth of knowledge and experience, and has been an equity research analyst for over 25 years. His diverse educational background, as well as his international financial services experience, gives him unique insights across the pharmaceuticals and financial services industries – a complex but increasingly interconnected landscape.

Chris earned his Bachelor of Pharmacy from the University of Sydney, and went on to build a successful community pharmacy practice. These years provided him with a solid commercial foundation and valuable hands-on experience in the Australian healthcare sector.

Building upon this real-world healthcare business experience, Chris completed a Master of Business Administration at the Australian Graduate School of Management (University of New South Wales), and then obtained a Master of Applied Finance from Macquarie University. Chris went on to achieve the Chartered Financial Analyst (CFA) designation, a globally recognised certification for investment professionals who are committed to maintaining the highest standards of integrity and professionalism in the financial industry. He is also a Graduate of the Australian Institute of Company Directors (AICD), the world’s largest non-profit membership organisation for directors.

Chris keeps a keen eye on the continuing evolution of the life sciences industry and is committed to helping bridge the information gap between pharmaceuticals, business strategy and finance. He is focused on ongoing education and professional development in order to stay at the forefront of industry trends and best practices.